Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Benzocaine | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.51E-02 | 1 | P51649 | ALDH5A1 | More | | Benzocaine | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Benzocaine | hsa00531 | Glycosaminoglycan degradation | 3.97E-05 | 2 | P15586, P34059 | GNS, GALNS | More | | Benzocaine | hsa00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 2.92E-02 | 1 | Q9Y2C2 | UST | More | | Benzocaine | hsa01524 | Platinum drug resistance | 2.55E-02 | 2 | P04637, P48023 | TP53, FASLG | More | | Benzocaine | hsa03008 | Ribosome biogenesis in eukaryotes | 2.06E-02 | 2 | Q9NYH9, Q9BVP2 | UTP6, GNL3 | More | | Benzocaine | hsa03040 | Spliceosome | 3.17E-02 | 6 | Q14562, O43143, Q07955, Q13243, P11142, O75643 | DHX8, DHX15, SFRS1, SFRS5, HSPA8, ASCC3L1 | More | | Benzocaine | hsa03050 | Proteasome | 3.93E-02 | 1 | P62195 | PSMC5 | More | | Benzocaine | hsa04012 | ErbB signaling pathway | 4.28E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Benzocaine | hsa04064 | NF-kappa B signaling pathway | 2.63E-03 | 11 | P10415, O00463, P01375, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q13315, P24522, P09341 | BCL2, TRAF5, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, ATM, GADD45A, CXCL1 | More | | Benzocaine | hsa04068 | FoxO signaling pathway | 6.45E-03 | 2 | P48023, Q96BR1 | FASLG, SGK3 | More | | Benzocaine | hsa04070 | Phosphatidylinositol signaling system | 2.56E-02 | 4 | P19174, P0DP23, P23743, P27987 | PLCG1, CALM1, DGKA, ITPKB | More | | Benzocaine | hsa04140 | Autophagy - animal | 4.55E-02 | 5 | P22694, Q14643, P10415, Q9H1Y0, Q04759 | PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Benzocaine | hsa04141 | Protein processing in endoplasmic reticulum | 3.07E-02 | 5 | P30101, P60604, P11142, P08238, Q9UNL2 | PDIA3, UBE2G2, HSPA8, HSP90AB1, SSR3 | More | | Benzocaine | hsa04142 | Lysosome | 1.14E-02 | 3 | P43234, P15586, P34059 | CTSO, GNS, GALNS | More | | Benzocaine | hsa04145 | Phagosome | 3.69E-02 | 7 | O75015, Q15080, P05164, P78380, O60603, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, TLR2, THBS4, HLA-DOB | More | | Benzocaine | hsa04151 | PI3K-Akt signaling pathway | 4.21E-03 | 3 | P48023, P04637, Q96BR1 | FASLG, TP53, SGK3 | More | | Benzocaine | hsa04210 | Apoptosis | 9.18E-03 | 4 | P04637, P24522, P43234, P63261 | TP53, GADD45A, CTSO, ACTG1 | More | | Benzocaine | hsa04371 | Apelin signaling pathway | 1.96E-02 | 5 | P62873, P63218, Q13370, Q14814, P0DP23 | GNB1, GNG5, PDE3B, MEF2D, CALM1 | More | | Benzocaine | hsa04612 | Antigen processing and presentation | 3.69E-02 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Benzocaine | hsa04613 | Neutrophil extracellular trap formation | 2.16E-02 | 7 | P19174, P11215, Q13547, Q93077, P62807, O60814, P60709 | PLCG1, ITGAM, HDAC1, HIST1H2AC, HIST1H2BC, H2BC12, ACTB | More | | Benzocaine | hsa04640 | Hematopoietic cell lineage | 4.72E-02 | 8 | P13612, P27930, P15144, P25063, P09693, P01732, P13765, P01375 | ITGA4, IL1R2, ANPEP, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Benzocaine | hsa04650 | Natural killer cell mediated cytotoxicity | 3.19E-03 | 11 | P01375, P06239, O60880, P20963, P48023, Q13241, P26718, O75015, P26717, Q14953, P26715 | TNF, LCK, SH2D1A, CD247, FASLG, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Benzocaine | hsa04658 | Th1 and Th2 cell differentiation | 2.41E-04 | 13 | Q04759, P07766, P20963, P09693, P19174, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, PLCG1, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Benzocaine | hsa04659 | Th17 cell differentiation | 2.42E-03 | 13 | Q04759, P19174, P06239, P42224, P14784, P13765, Q9HBE5, Q9UL17, P23771, P08238, P07766, P09693, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL21R, TBX21, GATA3, HSP90AB1, CD3E, CD3G, CD247 | More | | Benzocaine | hsa04660 | T cell receptor signaling pathway | 4.75E-03 | 10 | P01375, Q9UDY8, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, P06239 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, LCK | More | | Benzocaine | hsa04722 | Neurotrophin signaling pathway | 2.27E-02 | 2 | P48023, P04637 | FASLG, TP53 | More | | Benzocaine | hsa04744 | Phototransduction | 8.50E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Benzocaine | hsa04919 | Thyroid hormone signaling pathway | 2.48E-02 | 5 | P19174, P42224, P60709, Q13547, P01106 | PLCG1, STAT1, ACTB, HDAC1, MYC | More | | Benzocaine | hsa05010 | Alzheimer disease | 1.23E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Benzocaine | hsa05012 | Parkinson disease | 7.44E-03 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Benzocaine | hsa05014 | Amyotrophic lateral sclerosis | 2.32E-04 | 3 | P17861, P62195, Q53GS7 | XBP1, PSMC5, GLE1 | More | | Benzocaine | hsa05017 | Spinocerebellar ataxia | 1.95E-03 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Benzocaine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.63E-02 | 2 | P17861, P62195 | XBP1, PSMC5 | More | | Benzocaine | hsa05032 | Morphine addiction | 1.90E-02 | 4 | P62873, P63218, Q13370, P43250 | GNB1, GNG5, PDE3B, GRK6 | More | | Benzocaine | hsa05034 | Alcoholism | 1.49E-03 | 7 | Q13547, P0DP23, P62873, P63218, Q93077, P62807, O60814 | HDAC1, CALM1, GNB1, GNG5, HIST1H2AC, HIST1H2BC, H2BC12 | More | | Benzocaine | hsa05134 | Legionellosis | 4.28E-02 | 3 | P11215, P11142, P19875 | ITGAM, HSPA8, CXCL2 | More | | Benzocaine | hsa05140 | Leishmaniasis | 3.53E-02 | 6 | P13612, O75015, P13765, O60603, P01375, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, NCF4 | More | | Benzocaine | hsa05144 | Malaria | 1.14E-02 | 5 | P60033, O60603, P01375, P35443, P26718 | CD81, TLR2, TNF, THBS4, KLRK1 | More | | Benzocaine | hsa05146 | Amoebiasis | 1.95E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Benzocaine | hsa05160 | Hepatitis C | 3.81E-02 | 2 | P04637, P48023 | TP53, FASLG | More | | Benzocaine | hsa05164 | Influenza A | 3.48E-02 | 2 | Q9GZY0, P48023 | NXF2; NXF2B, FASLG | More | | Benzocaine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.64E-03 | 7 | P42224, P62873, P63218, P19875, P19174, P01106, P0DP23 | STAT1, GNB1, GNG5, CXCL2, PLCG1, MYC, CALM1 | More | | Benzocaine | hsa05168 | Herpes simplex virus 1 infection | 4.54E-03 | 4 | P04637, Q9GZY0, P48023, P98182 | TP53, NXF2; NXF2B, FASLG, ZNF200 | More | | Benzocaine | hsa05169 | Epstein-Barr virus infection | 3.56E-02 | 7 | P01106, Q13547, P30101, Q13761, O75293, P42224, P07766 | MYC, HDAC1, PDIA3, RUNX3, GADD45B, STAT1, CD3E | More | | Benzocaine | hsa05200 | Pathways in cancer | 2.60E-02 | 12 | P08238, P42224, P19174, P01106, P43246, P20585, Q13547, P62873, P63218, O75293, P0DP23, P14784 | HSP90AB1, STAT1, PLCG1, MYC, MSH2, MSH3, HDAC1, GNB1, GNG5, GADD45B, CALM1, IL2RB | More | | Benzocaine | hsa05202 | Transcriptional misregulation in cancer | 2.35E-02 | 12 | Q13315, P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | ATM, MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Benzocaine | hsa05203 | Viral carcinogenesis | 3.56E-02 | 6 | P06746, P29083, Q13547, P12814, P62807, O60814 | POLB, GTF2E1, HDAC1, ACTN1, HIST1H2BC, H2BC12 | More | | Benzocaine | hsa05205 | Proteoglycans in cancer | 4.43E-02 | 3 | P63261, P04637, Q06124 | ACTG1, TP53, PTPN11 | More | | Benzocaine | hsa05206 | MicroRNAs in cancer | 3.17E-02 | 6 | P30304, P09493, P01106, Q9Y4H2, Q13547, P19174 | CDC25A, TPM1, MYC, IRS2, HDAC1, PLCG1 | More | | Benzocaine | hsa05211 | Renal cell carcinoma | 7.75E-03 | 2 | Q06124, Q99814 | PTPN11, EPAS1 | More | | Benzocaine | hsa05212 | Pancreatic cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05213 | Endometrial cancer | 2.60E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05214 | Glioma | 3.45E-03 | 5 | P0DP23, P04637, P19174, P24522, O75293 | CALM1, TP53, PLCG1, GADD45A, GADD45B | More | | Benzocaine | hsa05216 | Thyroid cancer | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05217 | Basal cell carcinoma | 2.06E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05218 | Melanoma | 1.14E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05219 | Bladder cancer | 4.51E-02 | 1 | P04637 | TP53 | More | | Benzocaine | hsa05220 | Chronic myeloid leukemia | 7.90E-03 | 3 | Q06124, P04637, P24522 | PTPN11, TP53, GADD45A | More | | Benzocaine | hsa05223 | Non-small cell lung cancer | 3.19E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05224 | Breast cancer | 4.51E-02 | 2 | P04637, P24522 | TP53, GADD45A | More | | Benzocaine | hsa05225 | Hepatocellular carcinoma | 3.30E-02 | 3 | P04637, P24522, P63261 | TP53, GADD45A, ACTG1 | More | | Benzocaine | hsa05310 | Asthma | 1.92E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Benzocaine | hsa05321 | Inflammatory bowel disease | 1.30E-04 | 7 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Benzocaine | hsa05322 | Systemic lupus erythematosus | 4.50E-02 | 4 | Q93077, P62807, O60814, P12814 | HIST1H2AC, HIST1H2BC, H2BC12, ACTN1 | More | | Benzocaine | hsa05332 | Graft-versus-host disease | 2.17E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |